Clinical Trials in Dallas

Showing 10701-10720 of 17,468 trials

A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease

NCT03521180

This is a model development, open label, no therapeutic treatment, three sequential group, short term-gluten challenge study in subjects with celiac disease. Immune responses are evaluated following gluten challenge. Approximately fifteen subjects with celiac disease will be enrolled in up to three sequential groups (5 subjects per group).

Celiac Disease

Celgene5 participantsStarted May 2018

Dallas, Texas, United States • Seattle, Washington, United States

COMPLETEDPhase 4< 1 mile

A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB)

NCT02138747

The purpose of this study was to assess tolerability of mirabegron compared to tolterodine ER in the treatment of participants with symptoms of Overactive Bladder (OAB) as well as the impact of treatment on micturition frequency and incontinence episodes.

Overactive Bladder (OAB)

Astellas Pharma Global Development, Inc.376 participantsStarted Jul 2014

Homewood, Alabama, United States • Anchorage, Alaska, United States • Tucson, Arizona, United States +27 more locations

A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease

A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB)

Find Trials by Condition in Dallas

Prostate Cancer Intervention Versus Observation Trial (PIVOT)

Acute Renal Failure Post Liver Transplantation

Study to Investigate the Effects of Single Intravenous Doses of Difelikefalin (CR845) on the QTc Interval in Healthy Subjects

A Phase 3 Study of Tanezumab for Chronic Low Back Pain

Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)

Safety and Biological Activity of Vesatolimod in HIV-1 Infected, Virologically Suppressed Adults

Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects

Efficacy of Alicaforsen in Pouchitis Patients Who Have Failed to Respond to at Least One Course of Antibiotics

A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab

A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis

ANG1005 in Patients With Recurrent High-Grade Glioma

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Three-times Weekly Dosing of GSK1278863 in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease Who Are Switched From a Stable Dose of an Erythropoiesis-stimulating Agent

Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

Implant for Augmentation of Cerebral Blood Flow Trial, Effectiveness and Safety in a 24 Hour Window

In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers

Mitroflow DL Post Approval Study- North America

Study Testing Radium-223 Dichloride in Relapsed Multiple Myeloma

Enhancing the Public Health Impact of Latent Tuberculosis (TB) Infection Diagnosis and Treatment